Improper goat euthanasia lands antibody supplier with USDA complaint

By Dan Stanton contact

- Last updated on GMT

Santa Cruz Biotechnology accused of killing a goat with a bolt gun alone, by USDA
Santa Cruz Biotechnology accused of killing a goat with a bolt gun alone, by USDA
The US Department of Agriculture (USDA) has filed a complaint against antibody supplier Santa Cruz Biotechnology for its allegedly poor treatment of animals.

The Texas-headquartered supplier of research antibodies, reagents and purified proteins received the complaint from the USDA earlier this month, accusing the firm of wilfully violating the Animal Welfare Act in its treatment of goats and rabbits at its sites.

The alleged violations include an incident dating from July 7 this year when, according to the Agency’s complaint, the company failed to follow its own standard operating procedure for emergency euthanasia of a goat suffering with urinary calculi.

“At approximately 10.30 a.m., APHIS [Animal and Plant Health Inspection Service] inspectors found the goat in a depressed posture, unwilling to walk, and breathing heavily… By 3.30 p.m., the goat was agonal, suffering and in distress.

“As no veterinarian was available, respondent’s staff used a captive bolt gun alone (without a sedative or secondary euthanasia injection), to effect euthanasia of the goat at approximately 4.15 p.m.,”​ the complaint continued.

The USDA also cited Santa Cruz Biotechnology’s failure to meet the standards for handling rabbits on and around the same day, along with 13 other alleged violations dating back to September 2011.

The company did not respond to this publication’s requests by email and telephone for comment regarding the USDA’s allegations.

History of allegations

But in a statement, Michael Budkie, executive director of animal rights group SAEN, said: “We hope the government throws the book at Santa Cruz Biotech, which has a long history of animal abuse.”

He added this is the third complaint against Santa Cruz Biotechnology, which “is unprecedented by the USDA.”

In July 2010, the company resolved alleged violations from between October 2002 and December 2004 by paying a civil penalty of $4,600.

However, according to the USDA complaint, the firm has since been repeatedly cited by the APHIS for noncompliance with regulation and standards, as well as demonstrating bad faith by misleading the Agency about the existence of an undisclosed site which housed animals.

Related news

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars